Skip to main content

Table 5 The strains used in seasonal influenza vaccines from 2001 to 2015 and amino acid residue(s) of potential N-linked glycosylation sites on the globular head of HA in these strains

From: Re-emergence of H3N2 strains carrying potential neutralizing mutations at the N-linked glycosylation site at the hemagglutinin head, post the 2009 H1N1 pandemic

Year Northern hemisphere Amino acid residue(s) Southern hemisphere Amino acid residue(s)
144 144-146 144 144-146
2014–15 A/Texas/50/2012 (H3N2) N NNS A/Switzerland/9715293/2013 (H3N2) N NSS
2013–14 A/Victoria/361/2011(H3N2) N NNS A/Texas/50/2012 (H3N2) N NNS
2012–13 A/Victoria/361/2011(H3N2) N NNS A/Victoria/361/2011(H3N2) N NNS
2011–12 A/Perth/16/2009 (H3N2) K KNS A/Perth/16/2009 (H3N2) K KNS
2010–11 A/Perth/16/2009 (H3N2) K KNS A/Perth/16/2009 (H3N2) K KNS
2009–10 A/Brisbane/10/2007 (H3N2) N NNS A/Perth/16/2009 (H3N2) K KNS
2008–09 A/Brisbane/10/2007 (H3N2) N NNS A/Brisbane/10/2007 (H3N2) N NNS
2007–08 A/Wisconsin/67/2005 (H3N2) N NNS A/Brisbane/10/2007 (H3N2) N NNS
2006–07 A/Wisconsin/67/2005 (H3N2) N NNS A/Wisconsin/67/2005 (H3N2) N NNS
2005–06 A/California/7/2004(H3N2) N NNS A/California/7/2004(H3N2) N NNS
2004–05 A/Fujian/411/2002(H3N2) N NKS A/Wellington/1/2004(H3N2) N NKS
2003–04 A/Moscow/10/99(H3N2) I INS A/Fujian/411/2002(H3N2) N NKS
2002–03 A/Moscow/10/99(H3N2) I INS A/Moscow/10/99(H3N2) I INS
2001–02 A/Moscow/10/99(H3N2) I INS A/Moscow/10/99(H3N2) I INS